Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial

IMPORTANCE: Currently, preoperative radiotherapy for all soft-tissue sarcomas is identical at a 50-Gy dose level, which can be associated with morbidity, particularly wound complications. The observed clinical radiosensitivity of the myxoid liposarcoma subtype might offer the possibility to reduce m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:JAMA Oncol
Autori principali: Lansu, Jules, Bovée, Judith V. M. G., Braam, Pètra, van Boven, Hester, Flucke, Uta, Bonenkamp, Johannes J., Miah, Aisha B., Zaidi, Shane H., Thway, Khin, Bruland, Øyvind S., Baldini, Elizabeth H., Jebsen, Nina L., Scholten, Astrid N., van den Ende, Piet L. A., Krol, Augustinus D. G., Ubbels, Jan F., van der Hage, Jos A., van Werkhoven, Erik, Klomp, Houke M., van der Graaf, Winette T. A., van Coevorden, Frits, Schrage, Yvonne, van Houdt, Winan J., Haas, Rick L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Medical Association 2020
Soggetti:
Original Investigation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7662477/
https://ncbi.nlm.nih.gov/pubmed/33180100
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.5865
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi